Skip to main content

Advertisement

SpringerLink
Log in

Enhancement in the Transdermal and Localized Delivery of Honokiol Through Breast Tissue

  • Research Article
  • Theme: Advances in Topical Delivery of Drugs
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Honokiol is a natural phenolic anti-cancer compound isolated from an extract of seed cones from Magnolia grandiflora. This study investigated the transdermal delivery of honokiol using various enhancement methods and to explore the potential of honokiol to treat breast cancer directly via delivery through mammary papilla. Poration of dermatomed human skin with microneedles significantly increased the delivery of honokiol by nearly 3-fold (97.81 ± 18.96 μg/cm2) compared with passive delivery (32.56 ± 5.67 μg/cm2). Oleic acid was found to be the best chemical penetration enhancer, increasing the delivery almost 27-fold (868.06 ± 100.91 μg/cm2). Addition of oleic acid also resulted in better retention of drug in the porcine mammary papilla (965.41 ± 80.26 μg/cm2) compared with breast skin (294.16 ± 8.49 μg/cm2). Anti-cancer effect of honokiol was demonstrated with the decrease in the release of cytokine IL-6 and further suppression of Ki-67 proliferative protein. In addition, the topical honokiol formulation investigated was found to be safe and non-irritant. In summary, both microneedles and chemical enhancers can improve the absorption of honokiol through skin. Directly applying honokiol on mammary papilla is a potential administration route which can increase localized delivery into breast tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. American Cancer Society. (2015) Cancer facts and figures 2015.

  2. American Cancer Society. (2017) How common is breast cancer? [Internet]. Available at: https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. Accessed 23 May 2017

  3. Breastcancer.org (2017) U.S. breast cancer statics. [Internet]. Available at: http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed 23 May 2017

  4. Love SM, Barsky SH. Anatomy of the nipple and breast ducts revisited. Cancer. 2004;101:1947–57.

    Article  Google Scholar 

  5. Lee LM, Davison Z, Heard CM. In vitro delivery of anti-breast cancer agents directly via the mammary papillae (nipple). Int J Pharm. 2010;387(1–2):161–6.

    Article  CAS  Google Scholar 

  6. Lee Y-J, Lee YM, Lee C-K, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011;130(2):157–76.

    Article  CAS  Google Scholar 

  7. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med. 1983;49:103–8.

    Article  CAS  Google Scholar 

  8. Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 2012;14:R35.

    Article  CAS  Google Scholar 

  9. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, et al. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer. 2007;109:1279–89.

    Article  CAS  Google Scholar 

  10. Deng J, Qian Y, Geng L, Chen J, Wang X, Xie H, et al. Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int. 2008;28:1458–64.

    Article  CAS  Google Scholar 

  11. Tsai TH, Chou CJ, Lee TF, Wang LCH, Chen CF. Pharmacokinetic and pharmacodynamic studies of magnolol after oral administration in rats. Pharmaceut Sci. 1996;2:191–3.

    CAS  Google Scholar 

  12. Bronaugh RL, Maibach HI. Percutaneous absorption. 4th ed. New York: Marcel Dekker; 2005.

    Book  Google Scholar 

  13. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–24.

    Article  CAS  Google Scholar 

  14. Banga AK. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies. New York: CRC Press; 2011. p. 1–285.

    Book  Google Scholar 

  15. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv. 2009;6:343–54.

    Article  CAS  Google Scholar 

  16. William AC, Barry BW. Penetration enhancer. Adv Drug Deliv. 2004;56:603–18.

    Article  Google Scholar 

  17. Barry BW. Lipid–protein-partititioning theory of skin penetration enhancement. J Control Release. 1991;15:237–48.

    Article  CAS  Google Scholar 

  18. Medical College of Georgia at Augusta University. (2017) Cancer therapy shows promise for psoriasis treatment. [Internet] ScienceDaily. Available at: www.sciencedaily.com/releases/2017/05/170531110758.htm. Accessed 31 May 2017

  19. Dong HR, Liu XQ. HPLC analysis of magnolol and honokiol in magnoliae cortex after solvent sublation. Acta Chromatographica. 2008;20:147–56.

    Article  CAS  Google Scholar 

  20. MatTek Corporation (2017) In vitro EpiDerm TM skin irritation test (EPI-200-SIT) [Internet]. Available at: https://www.mattek.com/wp-content/uploads/Skin-Irritation-Test-Protocol.pdf. Accessed 12 April 2017

  21. Rusby JE, Brachtel EF, Michaelson JS, Koerner FC, Smith BL. Breast duct anatomy in the human nipple: Threedimensional patterns and clinical implications. Breast Cancer Res Treat. 2007;106:171–9.

    Article  Google Scholar 

  22. Murata S, Kominsky SL, Vali M, Zhang Z, Garrett-Mayer E, Korz D, et al. Ductal access for prevention and therapy of mammary tumours. Cancer Res. 2006;66:638–45.

    Article  CAS  Google Scholar 

  23. Dave K, Averineni R, Sahdev P, Perumal O. Transpapillaery drug delivery to the breastPLoS One. 2014;9(12):e115712.

    Article  Google Scholar 

  24. Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, et al. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol. 2008;140:95–102.

    Article  CAS  Google Scholar 

  25. Garcia A, Zheng Y, Zhao C, Toschi A, Fan J, Shraibman N, et al. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clin Cancer Res. 2008;14:4267–74.

    Article  CAS  Google Scholar 

  26. Zheng X, Wang X, Gou M, Zhang J, Men K, Chen L, et al. A novel transdermal honokiol formulation based on Pluronic F127 copolymer. Drug Deliv. 2010;17(3):138–44.

    Article  CAS  Google Scholar 

  27. Wang XH, Cai LL, Zhang XY, Deng LY, Zheng H, Deng CY, et al. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Int J Pharm. 2011;410:169–74.

    Article  CAS  Google Scholar 

  28. Mortazavi SA, Aboofazeli R. An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam. Iran J Pharm Res. 2003;2:135–40.

    CAS  Google Scholar 

  29. Wen Z, Fang L, He Z. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro. Drug Deliv. 2009;16(4):214–23.

    Article  CAS  Google Scholar 

  30. Vaddi HK, Wang LZ, Ho PC, Chan SY. Effect of some enhancers on the permeation of haloperidol through rat skin in vitro. Int J Pharm. 2001;212(2):247–55.

    Article  CAS  Google Scholar 

  31. Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancercontaining vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 2009;380(1–2):72–9.

    Article  CAS  Google Scholar 

  32. Sato A, Friend O, Nagai I. Effect and mode of action of aliphatic esters. Int J Pharm. 1988;43:31–40.

    Article  CAS  Google Scholar 

  33. Suomela S, Elomaa O, Skoog T, Ala-aho R, Jeskanen L, Pärssinen J, et al. CCHCR1 is up-regulated in skin cancer and associated with EGFR expression. PLoS One. 2009;4(6):e6030. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696036/. Accessed 11 Aug 2017

    Article  Google Scholar 

  34. Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med. 2012 Dec;12(10):1244–52.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Drug Delivery, Department of Pharmaceutical Sciences, Mercer University, Atlanta, Georgia, 30341, USA

    Xinyi Gao, Meera Gujjar Patel, Pooja Bakshi & Ajay K. Banga

  2. Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231, USA

    Dipali Sharma

Authors
  1. Xinyi Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meera Gujjar Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pooja Bakshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dipali Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ajay K. Banga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay K. Banga.

Additional information

Guest Editor: S. Narasimha Murthy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, X., Patel, M.G., Bakshi, P. et al. Enhancement in the Transdermal and Localized Delivery of Honokiol Through Breast Tissue. AAPS PharmSciTech 19, 3501–3511 (2018). https://doi.org/10.1208/s12249-018-1158-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-018-1158-1

KEY WORDS

Search

Navigation